Rossmore Private Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.96M | Sell |
57,421
-9,661
| -14% | -$1.12M | 0.61% | 38 |
|
|
2025
Q4 | $7.12M | Buy |
67,082
+4,504
| +7% | +$423K | 0.63% | 35 |
|
|
2025
Q3 | $5.25M | Sell |
62,578
-4,032
| -6% | -$332K | 0.57% | 41 |
|
|
2025
Q2 | $5.27M | Sell |
66,610
-5,026
| -7% | -$400K | 0.62% | 40 |
|
|
2025
Q1 | $6.43M | Sell |
71,636
-668
| -0.9% | -$62.4K | 0.79% | 33 |
|
|
2024
Q4 | $7.19M | Sell |
72,304
-594
| -0.8% | -$61.2K | 0.89% | 29 |
|
|
2024
Q3 | $8.28M | Buy |
72,898
+430
| +0.6% | +$51.1K | 1.02% | 26 |
|
|
2024
Q2 | $8.97M | Sell |
72,468
-779
| -1% | -$100K | 1.18% | 19 |
|
|
2024
Q1 | $9.66M | Sell |
73,247
-220
| -0.3% | -$27.1K | 1.26% | 18 |
|
|
2023
Q4 | $8.01M | Sell |
73,467
-152
| -0.2% | -$15.8K | 1.13% | 24 |
|
|
2023
Q3 | $7.58M | Buy |
73,619
+36
| +0% | +$3.88K | 1.15% | 20 |
|
|
2023
Q2 | $8.49M | Buy |
73,583
+2,492
| +4% | +$283K | 1.26% | 16 |
|
|
2023
Q1 | $7.56M | Sell |
71,091
-278
| -0.4% | -$30K | 1.18% | 18 |
|
|
2022
Q4 | $7.92M | Sell |
71,369
-373
| -0.5% | -$38.1K | 1.27% | 16 |
|
|
2022
Q3 | $6.18M | Buy |
71,742
+2,068
| +3% | +$185K | 1.11% | 22 |
|
|
2022
Q2 | $6.35M | Buy |
69,674
+1,971
| +3% | +$175K | 1.1% | 22 |
|
|
2022
Q1 | $5.55M | Sell |
67,703
-2,166
| -3% | -$171K | 0.86% | 28 |
|
|
2021
Q4 | $5.36M | Buy |
69,869
+16,778
| +32% | +$1.34M | 0.84% | 30 |
|
|
2021
Q3 | $3.99M | Buy |
53,091
+535
| +1% | +$40.7K | 0.68% | 38 |
|
|
2021
Q2 | $4.09M | Sell |
52,556
-2,536
| -5% | -$189K | 0.7% | 38 |
|
|
2021
Q1 | $4.05M | Sell |
55,092
-9,665
| -15% | -$713K | 0.76% | 34 |
|
|
2020
Q4 | $5.05M | Buy |
64,757
+2,905
| +5% | +$222K | 1.02% | 26 |
|
|
2020
Q3 | $4.9M | Buy |
61,852
+11,172
| +22% | +$875K | 1.15% | 21 |
|
|
2020
Q2 | $3.74M | Buy |
50,680
+4,218
| +9% | +$318K | 1.03% | 24 |
|
|
2020
Q1 | $3.41M | Buy |
46,462
+13,231
| +40% | +$1.04M | 1.18% | 20 |
|
|
2019
Q4 | $2.88M | Buy |
33,231
+13,340
| +67% | +$1.1M | 0.89% | 29 |
|
|
2019
Q3 | $1.6M | Buy |
19,891
+7,179
| +56% | +$575K | 0.54% | 42 |
|
|
2019
Q2 | $1.02M | Buy |
12,712
+2,400
| +23% | +$184K | 0.36% | 54 |
|
|
2019
Q1 | $818K | Sell |
10,312
-46
| -0.4% | -$3.44K | 0.3% | 59 |
|
|
2018
Q4 | $755K | Hold |
10,358
| – | – | 0.32% | 61 |
|
|
2018
Q3 | $701K | Buy |
+10,358
| New | +$660K | 0.28% | 63 |
|
|
2018
Q1 | – | Sell |
-8,405
| Closed | -$451K | – | 294 |
|
|
2017
Q4 | $451K | Buy |
+8,405
| New | +$466K | 0.45% | 48 |
|
Other funds holding MRK
VCM
VPM
Rossmore Private Capital's MRK Position: Q1 2026 in Review
Rossmore Private Capital reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $1.12M and leaving 57,421 shares worth $6.96M. The position accounts for 0.61% of the portfolio, ranked #38.
Rossmore Private Capital first reported a position in MRK in Q4 2017 and has held it in 32 quarters since. The position peaked at $9.66M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Rossmore Private Capital held 57,421 shares of Merck worth $6.96M as of Q1 2026.
- Rossmore Private Capital sold 9,661 Merck shares in Q1 2026, an estimated $1.12M.
- Merck made up 0.61% of Rossmore Private Capital's portfolio in Q1 2026, its #38 holding.
- Rossmore Private Capital first reported a position in Merck in Q4 2017 and has held it in 32 quarters since.
- Rossmore Private Capital's Merck position peaked at $9.66M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Rossmore Private Capital's 13F filing for Q1 2026, filed 1 May 2026.